aluates Reports

$ 0.0

Automative

Global Glucagon Market Research Report 2026

Published Date: 2026-01-21

Report Code: QYRE-Auto-19M646

Global Glucagon Market Insights and Forecast to 2028

BUY CHAPTERS

Global Glucagon Market Research Report 2026

Code: QYRE-Auto-19M646

Report

2026-01-21

Pages:110

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Novo Nordisk

Eli Lilly

Fresenius Kabi

Torrent Labs

Taj Pharmaceuticals

Xeris Pharmaceuticals

Glucagon Market Size

The global Glucagon market was valued at US$ 660 million in 2025 and is anticipated to reach US$ 993 million by 2032, at a CAGR of 6.1% from 2026 to 2032.

Glucagon Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Glucagon competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.

Glucagon is a metabolic hormone secreted by the pancreas that raises blood glucose levels by causing the liver to rapidly convert glycogen (the stored form of glucose) into glucose, which is then released into the bloodstream. Glucagon and insulin are two critical hormones in a glycemic control system that keeps blood glucose at the right level in healthy individual. Glucagon is a medicine which used to treat severe low blood sugar (hypoglycemia). Glucagon works by telling your body to release sugar (glucose) into the bloodstream to bring the blood sugar level back up.

Global Glucagon main players are Novo Nordisk, Eli Lilly, Fresenius Kabi, Torrent Labs, etc. Global top four manufacturers hold a share over 80%. North America is the largest market, with a share nearly 40%.

This report delivers a comprehensive overview of the global Glucagon market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Glucagon. The Glucagon market size, estimates, and forecasts are provided in terms of sales volume (K MT) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Glucagon market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Glucagon manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of Glucagon Market Report

Report Metric	Details
Report Name	Glucagon Market
Accounted market size in 2025	US$ 660 million
Forecasted market size in 2032	US$ 993 million
CAGR	6.1%
Base Year	2025
Forecasted years	2026 - 2032
Segment by Type	Inject Glucagon Nasal Glucagon
by Application	Emergency Kits General Use Diagnostic & Motility Cardiogenic Shock Others
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Novo Nordisk, Eli Lilly, Fresenius Kabi, Torrent Labs, Taj Pharmaceuticals, Xeris Pharmaceuticals
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Glucagon manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Glucagon sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

How fast is Glucagon Market growing?

Ans: The Glucagon Market witnessing a CAGR of 6.1% during the forecast period 2026-2032.

What is the Glucagon Market size in 2032?

Ans: The Glucagon Market size in 2032 will be US$ 993 million.

What is the market share of major companies in Glucagon Market?

Ans: Global top four manufacturers hold a share over 80%.

What is the Glucagon Market share by region?

Ans: North America is the largest market, with a share nearly 40%.

Who are the main players in the Glucagon Market report?

Ans: The main players in the Glucagon Market are Novo Nordisk, Eli Lilly, Fresenius Kabi, Torrent Labs, Taj Pharmaceuticals, Xeris Pharmaceuticals

What are the Application segmentation covered in the Glucagon Market report?

Ans: The Applications covered in the Glucagon Market report are Emergency Kits, General Use, Diagnostic & Motility, Cardiogenic Shock, Others

What are the Type segmentation covered in the Glucagon Market report?

Ans: The Types covered in the Glucagon Market report are Inject Glucagon, Nasal Glucagon

1 Glucagon Market Overview

1.1 Product Definition

1.2 Glucagon by Type

1.2.1 Global Glucagon Market Value by Type: 2025 vs 2032

1.2.2 Inject Glucagon

1.2.3 Nasal Glucagon

1.3 Glucagon by Application

1.3.1 Global Glucagon Market Value by Application: 2025 vs 2032

1.3.2 Emergency Kits

1.3.3 General Use

1.3.4 Diagnostic & Motility

1.3.5 Cardiogenic Shock

1.3.6 Others

1.4 Global Glucagon Market Size Estimates and Forecasts

1.4.1 Global Glucagon Revenue 2021–2032

1.4.2 Global Glucagon Sales 2021–2032

1.4.3 Global Glucagon Market Average Price (2021–2032)

1.5 Assumptions and Limitations

2 Glucagon Market Competition by Manufacturers

2.1 Global Glucagon Sales Market Share by Manufacturers (2021–2026)

2.2 Global Glucagon Revenue Market Share by Manufacturers (2021–2026)

2.3 Global Glucagon Average Price by Manufacturers (2021–2026)

2.4 Global Key Players of Glucagon, Industry Ranking, 2023 vs 2024 vs 2025

2.5 Global Key Manufacturers of Glucagon, Manufacturing Sites and Headquarters

2.6 Global Key Manufacturers of Glucagon, Product Types and Applications

2.7 Global Key Manufacturers of Glucagon, Date of Entry into the Industry

2.8 Global Glucagon Market Competitive Situation and Trends

2.8.1 Global Glucagon Market Concentration Rate

2.8.2 The Top 5 and Top 10 Global Glucagon Players Market Share by Revenue

2.8.3 Global Glucagon Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Glucagon Market Scenario by Region

3.1 Global Glucagon Market Size by Region: 2021 vs 2025 vs 2032

3.2 Global Glucagon Sales by Region: 2021–2032

3.2.1 Global Glucagon Sales by Region: 2021–2026

3.2.2 Global Glucagon Sales by Region: 2027–2032

3.3 Global Glucagon Revenue by Region: 2021–2032

3.3.1 Global Glucagon Revenue by Region: 2021–2026

3.3.2 Global Glucagon Revenue by Region: 2027–2032

3.4 North America Glucagon Market Facts & Figures by Country

3.4.1 North America Glucagon Market Size by Country: 2021 vs 2025 vs 2032

3.4.2 North America Glucagon Sales by Country (2021–2032)

3.4.3 North America Glucagon Revenue by Country (2021–2032)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Glucagon Market Facts & Figures by Country

3.5.1 Europe Glucagon Market Size by Country: 2021 vs 2025 vs 2032

3.5.2 Europe Glucagon Sales by Country (2021–2032)

3.5.3 Europe Glucagon Revenue by Country (2021–2032)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Glucagon Market Facts & Figures by Region

3.6.1 Asia Pacific Glucagon Market Size by Region: 2021 vs 2025 vs 2032

3.6.2 Asia Pacific Glucagon Sales by Region (2021–2032)

3.6.3 Asia Pacific Glucagon Revenue by Region (2021–2032)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.7 Latin America Glucagon Market Facts & Figures by Country

3.7.1 Latin America Glucagon Market Size by Country: 2021 vs 2025 vs 2032

3.7.2 Latin America Glucagon Sales by Country (2021–2032)

3.7.3 Latin America Glucagon Revenue by Country (2021–2032)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Glucagon Market Facts & Figures by Country

3.8.1 Middle East and Africa Glucagon Market Size by Country: 2021 vs 2025 vs 2032

3.8.2 Middle East and Africa Glucagon Sales by Country (2021–2032)

3.8.3 Middle East and Africa Glucagon Revenue by Country (2021–2032)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Glucagon Sales by Type (2021–2032)

4.1.1 Global Glucagon Sales by Type (2021–2026)

4.1.2 Global Glucagon Sales by Type (2027–2032)

4.1.3 Global Glucagon Sales Market Share by Type (2021–2032)

4.2 Global Glucagon Revenue by Type (2021–2032)

4.2.1 Global Glucagon Revenue by Type (2021–2026)

4.2.2 Global Glucagon Revenue by Type (2027–2032)

4.2.3 Global Glucagon Revenue Market Share by Type (2021–2032)

4.3 Global Glucagon Price by Type (2021–2032)

5 Segment by Application

5.1 Global Glucagon Sales by Application (2021–2032)

5.1.1 Global Glucagon Sales by Application (2021–2026)

5.1.2 Global Glucagon Sales by Application (2027–2032)

5.1.3 Global Glucagon Sales Market Share by Application (2021–2032)

5.2 Global Glucagon Revenue by Application (2021–2032)

5.2.1 Global Glucagon Revenue by Application (2021–2026)

5.2.2 Global Glucagon Revenue by Application (2027–2032)

5.2.3 Global Glucagon Revenue Market Share by Application (2021–2032)

5.3 Global Glucagon Price by Application (2021–2032)

6 Key Companies Profiled

6.1 Novo Nordisk

6.1.1 Novo Nordisk Company Information

6.1.2 Novo Nordisk Description and Business Overview

6.1.3 Novo Nordisk Glucagon Sales, Revenue, and Gross Margin (2021–2026)

6.1.4 Novo Nordisk Glucagon Product Portfolio

6.1.5 Novo Nordisk Recent Developments/Updates

6.2 Eli Lilly

6.2.1 Eli Lilly Company Information

6.2.2 Eli Lilly Description and Business Overview

6.2.3 Eli Lilly Glucagon Sales, Revenue, and Gross Margin (2021–2026)

6.2.4 Eli Lilly Glucagon Product Portfolio

6.2.5 Eli Lilly Recent Developments/Updates

6.3 Fresenius Kabi

6.3.1 Fresenius Kabi Company Information

6.3.2 Fresenius Kabi Description and Business Overview

6.3.3 Fresenius Kabi Glucagon Sales, Revenue, and Gross Margin (2021–2026)

6.3.4 Fresenius Kabi Glucagon Product Portfolio

6.3.5 Fresenius Kabi Recent Developments/Updates

6.4 Torrent Labs

6.4.1 Torrent Labs Company Information

6.4.2 Torrent Labs Description and Business Overview

6.4.3 Torrent Labs Glucagon Sales, Revenue, and Gross Margin (2021–2026)

6.4.4 Torrent Labs Glucagon Product Portfolio

6.4.5 Torrent Labs Recent Developments/Updates

6.5 Taj Pharmaceuticals

6.5.1 Taj Pharmaceuticals Company Information

6.5.2 Taj Pharmaceuticals Description and Business Overview

6.5.3 Taj Pharmaceuticals Glucagon Sales, Revenue, and Gross Margin (2021–2026)

6.5.4 Taj Pharmaceuticals Glucagon Product Portfolio

6.5.5 Taj Pharmaceuticals Recent Developments/Updates

6.6 Xeris Pharmaceuticals

6.6.1 Xeris Pharmaceuticals Company Information

6.6.2 Xeris Pharmaceuticals Description and Business Overview

6.6.3 Xeris Pharmaceuticals Glucagon Sales, Revenue, and Gross Margin (2021–2026)

6.6.4 Xeris Pharmaceuticals Glucagon Product Portfolio

6.6.5 Xeris Pharmaceuticals Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Glucagon Industry Chain Analysis

7.2 Glucagon Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Glucagon Production Mode & Process Analysis

7.4 Glucagon Sales and Marketing

7.4.1 Glucagon Sales Channels

7.4.2 Glucagon Distributors

7.5 Glucagon Customer Analysis

8 Glucagon Market Dynamics

8.1 Glucagon Industry Trends

8.2 Glucagon Market Drivers

8.3 Glucagon Market Challenges

8.4 Glucagon Market Restraints

8.5 Impact of U.S. Tariffs

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Novo Nordisk

Eli Lilly

Fresenius Kabi

Torrent Labs

Taj Pharmaceuticals

Xeris Pharmaceuticals

List of Tables

Table 1. Global Glucagon Market Value by Type (US$ Million), 2025 vs 2032

Table 2. Global Glucagon Market Value by Application (US$ Million), 2025 vs 2032

Table 3. Global Glucagon Market Competitive Situation by Manufacturers in 2025

Table 4. Global Glucagon Sales (K MT) of Key Manufacturers (2021–2026)

Table 5. Global Glucagon Sales Market Share by Manufacturers (2021–2026)

Table 6. Global Glucagon Revenue (US$ Million) by Manufacturers (2021–2026)

Table 7. Global Glucagon Revenue Share by Manufacturers (2021–2026)

Table 8. Global Market Glucagon Average Price (USD/MT) of Key Manufacturers (2021–2026)

Table 9. Global Key Players of Glucagon, Industry Ranking, 2023 vs 2024 vs 2025

Table 10. Global Key Manufacturers of Glucagon, Manufacturing Sites and Headquarters

Table 11. Global Key Manufacturers of Glucagon, Product Types and Applications

Table 12. Global Key Manufacturers of Glucagon, Date of Entry into the Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Glucagon Companies by Tier (Tier 1, Tier 2, Tier 3), based on Glucagon Revenue, 2025

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Glucagon Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 17. Global Glucagon Sales by Region (K MT), 2021–2026

Table 18. Global Glucagon Sales Market Share by Region (2021–2026)

Table 19. Global Glucagon Sales by Region (K MT), 2027–2032

Table 20. Global Glucagon Sales Market Share by Region (2027–2032)

Table 21. Global Glucagon Revenue by Region (US$ Million), 2021–2026

Table 22. Global Glucagon Revenue Market Share by Region (2021–2026)

Table 23. Global Glucagon Revenue by Region (US$ Million), 2027–2032

Table 24. Global Glucagon Revenue Market Share by Region (2027–2032)

Table 25. North America Glucagon Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 26. North America Glucagon Sales by Country (K MT), 2021–2026

Table 27. North America Glucagon Sales by Country (K MT), 2027–2032

Table 28. North America Glucagon Revenue by Country (US$ Million), 2021–2026

Table 29. North America Glucagon Revenue by Country (US$ Million), 2027–2032

Table 30. Europe Glucagon Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 31. Europe Glucagon Sales by Country (K MT), 2021–2026

Table 32. Europe Glucagon Sales by Country (K MT), 2027–2032

Table 33. Europe Glucagon Revenue by Country (US$ Million), 2021–2026

Table 34. Europe Glucagon Revenue by Country (US$ Million), 2027–2032

Table 35. Asia Pacific Glucagon Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)

Table 36. Asia Pacific Glucagon Sales by Region (K MT), 2021–2026

Table 37. Asia Pacific Glucagon Sales by Region (K MT), 2027–2032

Table 38. Asia Pacific Glucagon Revenue by Region (US$ Million), 2021–2026

Table 39. Asia Pacific Glucagon Revenue by Region (US$ Million), 2027–2032

Table 40. Latin America Glucagon Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 41. Latin America Glucagon Sales by Country (K MT), 2021–2026

Table 42. Latin America Glucagon Sales by Country (K MT), 2027–2032

Table 43. Latin America Glucagon Revenue by Country (US$ Million), 2021–2026

Table 44. Latin America Glucagon Revenue by Country (US$ Million), 2027–2032

Table 45. Middle East and Africa Glucagon Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 46. Middle East and Africa Glucagon Sales by Country (K MT), 2021–2026

Table 47. Middle East and Africa Glucagon Sales by Country (K MT), 2027–2032

Table 48. Middle East and Africa Glucagon Revenue by Country (US$ Million), 2021–2026

Table 49. Middle East and Africa Glucagon Revenue by Country (US$ Million), 2027–2032

Table 50. Global Glucagon Sales (K MT) by Type (2021–2026)

Table 51. Global Glucagon Sales (K MT) by Type (2027–2032)

Table 52. Global Glucagon Sales Market Share by Type (2021–2026)

Table 53. Global Glucagon Sales Market Share by Type (2027–2032)

Table 54. Global Glucagon Revenue (US$ Million) by Type (2021–2026)

Table 55. Global Glucagon Revenue (US$ Million) by Type (2027–2032)

Table 56. Global Glucagon Revenue Market Share by Type (2021–2026)

Table 57. Global Glucagon Revenue Market Share by Type (2027–2032)

Table 58. Global Glucagon Price (USD/MT) by Type (2021–2026)

Table 59. Global Glucagon Price (USD/MT) by Type (2027–2032)

Table 60. Global Glucagon Sales (K MT) by Application (2021–2026)

Table 61. Global Glucagon Sales (K MT) by Application (2027–2032)

Table 62. Global Glucagon Sales Market Share by Application (2021–2026)

Table 63. Global Glucagon Sales Market Share by Application (2027–2032)

Table 64. Global Glucagon Revenue (US$ Million) by Application (2021–2026)

Table 65. Global Glucagon Revenue (US$ Million) by Application (2027–2032)

Table 66. Global Glucagon Revenue Market Share by Application (2021–2026)

Table 67. Global Glucagon Revenue Market Share by Application (2027–2032)

Table 68. Global Glucagon Price (USD/MT) by Application (2021–2026)

Table 69. Global Glucagon Price (USD/MT) by Application (2027–2032)

Table 70. Novo Nordisk Company Information

Table 71. Novo Nordisk Description and Business Overview

Table 72. Novo Nordisk Glucagon Sales (K MT), Revenue (US$ Million), Price (USD/MT), and Gross Margin (2021–2026)

Table 73. Novo Nordisk Glucagon Product

Table 74. Novo Nordisk Recent Developments/Updates

Table 75. Eli Lilly Company Information

Table 76. Eli Lilly Description and Business Overview

Table 77. Eli Lilly Glucagon Sales (K MT), Revenue (US$ Million), Price (USD/MT), and Gross Margin (2021–2026)

Table 78. Eli Lilly Glucagon Product

Table 79. Eli Lilly Recent Developments/Updates

Table 80. Fresenius Kabi Company Information

Table 81. Fresenius Kabi Description and Business Overview

Table 82. Fresenius Kabi Glucagon Sales (K MT), Revenue (US$ Million), Price (USD/MT), and Gross Margin (2021–2026)

Table 83. Fresenius Kabi Glucagon Product

Table 84. Fresenius Kabi Recent Developments/Updates

Table 85. Torrent Labs Company Information

Table 86. Torrent Labs Description and Business Overview

Table 87. Torrent Labs Glucagon Sales (K MT), Revenue (US$ Million), Price (USD/MT), and Gross Margin (2021–2026)

Table 88. Torrent Labs Glucagon Product

Table 89. Torrent Labs Recent Developments/Updates

Table 90. Taj Pharmaceuticals Company Information

Table 91. Taj Pharmaceuticals Description and Business Overview

Table 92. Taj Pharmaceuticals Glucagon Sales (K MT), Revenue (US$ Million), Price (USD/MT), and Gross Margin (2021–2026)

Table 93. Taj Pharmaceuticals Glucagon Product

Table 94. Taj Pharmaceuticals Recent Developments/Updates

Table 95. Xeris Pharmaceuticals Company Information

Table 96. Xeris Pharmaceuticals Description and Business Overview

Table 97. Xeris Pharmaceuticals Glucagon Sales (K MT), Revenue (US$ Million), Price (USD/MT), and Gross Margin (2021–2026)

Table 98. Xeris Pharmaceuticals Glucagon Product

Table 99. Xeris Pharmaceuticals Recent Developments/Updates

Table 100. Key Raw Materials Lists

Table 101. Raw Materials Key Suppliers Lists

Table 102. Glucagon Distributors List

Table 103. Glucagon Customers List

Table 104. Glucagon Market Trends

Table 105. Glucagon Market Drivers

Table 106. Glucagon Market Challenges

Table 107. Glucagon Market Restraints

Table 108. Research Programs/Design for This Report

Table 109. Key Data Information from Secondary Sources

Table 110. Key Data Information from Primary Sources

Table 111. Authors List of This Report

List of Figures

Figure 1. Product Picture of Glucagon

Figure 2. Global Glucagon Market Value by Type (US$ Million), 2021–2032

Figure 3. Global Glucagon Market Share by Type: 2025 & 2032

Figure 4. Inject Glucagon Product Picture

Figure 5. Nasal Glucagon Product Picture

Figure 6. Global Glucagon Market Value by Application (US$ Million), 2021–2032

Figure 7. Global Glucagon Market Share by Application: 2025 & 2032

Figure 8. Emergency Kits

Figure 9. General Use

Figure 10. Diagnostic & Motility

Figure 11. Cardiogenic Shock

Figure 12. Others

Figure 13. Global Glucagon Revenue, (US$ Million), 2021 vs 2025 vs 2032

Figure 14. Global Glucagon Market Size (US$ Million), 2021–2032

Figure 15. Global Glucagon Sales (K MT), 2021–2032

Figure 16. Global Glucagon Average Price (USD/MT), 2021–2032

Figure 17. Glucagon Report Years Considered

Figure 18. Glucagon Sales Share by Manufacturers in 2025

Figure 19. Global Glucagon Revenue Share by Manufacturers in 2025

Figure 20. Top 5 and Top 10 Global Glucagon Players: Market Share by Revenue in Glucagon in 2025

Figure 21. Glucagon Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025

Figure 22. Global Glucagon Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Figure 23. North America Glucagon Sales Market Share by Country (2021–2032)

Figure 24. North America Glucagon Revenue Market Share by Country (2021–2032)

Figure 25. U.S. Glucagon Revenue Growth Rate (US$ Million), 2021–2032

Figure 26. Canada Glucagon Revenue Growth Rate (US$ Million), 2021–2032

Figure 27. Europe Glucagon Sales Market Share by Country (2021–2032)

Figure 28. Europe Glucagon Revenue Market Share by Country (2021–2032)

Figure 29. Germany Glucagon Revenue Growth Rate (US$ Million), 2021–2032

Figure 30. France Glucagon Revenue Growth Rate (US$ Million), 2021–2032

Figure 31. U.K. Glucagon Revenue Growth Rate (US$ Million), 2021–2032

Figure 32. Italy Glucagon Revenue Growth Rate (US$ Million), 2021–2032

Figure 33. Russia Glucagon Revenue Growth Rate (US$ Million), 2021–2032

Figure 34. Asia Pacific Glucagon Sales Market Share by Region (2021–2032)

Figure 35. Asia Pacific Glucagon Revenue Market Share by Region (2021–2032)

Figure 36. China Glucagon Revenue Growth Rate (US$ Million), 2021–2032

Figure 37. Japan Glucagon Revenue Growth Rate (US$ Million), 2021–2032

Figure 38. South Korea Glucagon Revenue Growth Rate (US$ Million), 2021–2032

Figure 39. India Glucagon Revenue Growth Rate (US$ Million), 2021–2032

Figure 40. Australia Glucagon Revenue Growth Rate (US$ Million), 2021–2032

Figure 41. China Taiwan Glucagon Revenue Growth Rate (US$ Million), 2021–2032

Figure 42. Indonesia Glucagon Revenue Growth Rate (US$ Million), 2021–2032

Figure 43. Thailand Glucagon Revenue Growth Rate (US$ Million), 2021–2032

Figure 44. Malaysia Glucagon Revenue Growth Rate (US$ Million), 2021–2032

Figure 45. Latin America Glucagon Sales Market Share by Country (2021–2032)

Figure 46. Latin America Glucagon Revenue Market Share by Country (2021–2032)

Figure 47. Mexico Glucagon Revenue Growth Rate (US$ Million), 2021–2032

Figure 48. Brazil Glucagon Revenue Growth Rate (US$ Million), 2021–2032

Figure 49. Argentina Glucagon Revenue Growth Rate (US$ Million), 2021–2032

Figure 50. Middle East and Africa Glucagon Sales Market Share by Country (2021–2032)

Figure 51. Middle East and Africa Glucagon Revenue Market Share by Country (2021–2032)

Figure 52. Turkey Glucagon Revenue Growth Rate (US$ Million), 2021–2032

Figure 53. Saudi Arabia Glucagon Revenue Growth Rate (US$ Million), 2021–2032

Figure 54. UAE Glucagon Revenue Growth Rate (US$ Million), 2021–2032

Figure 55. Global Sales Market Share of Glucagon by Type (2021–2032)

Figure 56. Global Revenue Market Share of Glucagon by Type (2021–2032)

Figure 57. Global Glucagon Price (USD/MT) by Type (2021–2032)

Figure 58. Global Sales Market Share of Glucagon by Application (2021–2032)

Figure 59. Global Revenue Market Share of Glucagon by Application (2021–2032)

Figure 60. Global Glucagon Price (USD/MT) by Application (2021–2032)

Figure 61. Glucagon Value Chain

Figure 62. Channels of Distribution (Direct Vs Distribution)

Figure 63. Bottom-up and Top-down Approaches for This Report

Figure 64. Data Triangulation

Figure 65. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global GLP 1 Weight Loss Drug Market Research Report 2024

Global Hormonal Therapy for Type 2 Diabetes Market Research Report 2024

Global GLP 1 Peptide Drugs Market Research Report 2024

Global Medication for Diabetes Market Research Report 2024

Global GLP 1 based Therapy Market Research Report 2024

Global GLP 1 Injection Market Research Report 2024

Global GLP 1 Drug Peptide API Market Research Report 2024

Global Type 2 Diabetes Medications Market Research Report 2024

Global GLP 1RA Therapy Market Research Report 2024

Global Mealtime Insulin Market Research Report 2024

Global Hypoglycemic Drugs Market Insights Forecast to 2030

Glucagon Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Glucagon Injection Market Research Report 2025

GLP 1 for Diabetes Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Dulaglutide Market Research Report 2024

GLP 1 Analogues Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Somatostatin Sales Market Report Competitive Analysis and Regional Opportunities 2025 2031

Diabetes Drug Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Peptide Drugs for Diabetes Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions